ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
28 hedge funds and large institutions have $456K invested in Argos Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
8
Reduced
9
Closed
6
Calls
$615K
Puts
–
Net Calls
+$615K
Net Calls Change
-$305K
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$32K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$14.9K |
| 3 |
Bank of New York Mellon
New York
|
-$8.37K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$5K |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$3.37K |
